New brain device offers hope for autism symptoms in children
NCT ID NCT07276555
Summary
This study is testing whether a noninvasive brain stimulation device can safely improve core symptoms of autism in children. Researchers will enroll 256 children aged 3-12 with mild to moderate autism who use some spoken language. Half will receive real treatment sessions and half will receive placebo sessions, with neither families nor assessors knowing which is which, to see if the active treatment leads to greater improvement in social communication and behavior.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NeuroCytonix Mexico
San Pedro Garza García, Nuevo León, 66224, Mexico
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
NeuroCytonix, Inc.
Rockville, Maryland, 20850, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.